GLP-1 Drugs Inspire Precision Eating
Enhanced Cognitive Function and Mood Mental clarity and sharper thinking Improved memory and recall Mood enhancement and reduced anxiety Better stress resilience "The most noticeable was mental
Severe Kidney or Liver Disease and Drug Interaction Risks Patients with eGFR below 15 mL/min/1.73m (Stage 5 chronic kidney disease) or those on dialysis may not be suitable candidates for tirzepatide, as limited pharmacokinetic data exists in end-stage renal disease
You likely qualify if you have a BMI of 30 or higher (clinically classified as obesity), or BMI of 27 or higher with a weight-related condition such as type 2 diabetes, prediabetes, high blood pressure, high cholesterol, or obstructive sleep apnea
Why Individuals Stop Taking GLP-1 People might stop taking GLP-1 medications for several reasons, from cost issues to trouble accessing medication
Whether starting at 0.10 or tapering down to 0.05, we offer flexibility and support to help you comfortably and effectively achieve your body weight goals